FFRangio Software Matches Wire-Based Coronary Outcomes
A large international randomized trial presented at ACC.26 and published in the New England Journal of Medicine found that FFRangio, an AI-driven image-based software, produced similar one-year outcomes to invasive wire-based fractional flow reserve in 1,930 patients (6.9% vs 7.1% primary events). FFRangio was faster to perform and avoided additional catheters or hyperemic drugs, potentially increasing physiologic testing adoption pending cost analyses.
Key Points
- 1Demonstrates FFRangio matches wire-based testing with 6.9% versus 7.1% one-year primary events
- 2Suggests AI-based 3D angiography modelling can reduce procedural complexity and eliminate hyperemic drugs
- 3Enables faster, less invasive PCI guidance; may boost physiologic testing uptake if cost-effective
Scoring Rationale
Large, randomized NEJM-published trial presented at ACC provides high credibility and novelty; broad cardiology scope and strong relevance. Slight deduction for limited technical detail on AI methods and remaining cost/adoption questions.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problems
